Bridging from Intravenous to Subcutaneous Formulation of Tocilizumab for Optimal Dose Regimens in Polyarticular Juvenile Idiopathic Arthritis (pJIA)

被引：0
|
作者：
Gibiansky, Leonid [1 ]
Gibiansky, Ekaterina [1 ]
Frey, Nicolas [2 ]
Mallalieu, Navita L. [3 ]
Petry, Claire [2 ]
Charoin, Jean-Eric [2 ]
Douglass, Wendy [4 ]
Hsu, Joy C. [3 ]
机构：
[1] QuantPharm LLC, North Potomac, MD USA
[2] Roche Innovat Ctr, Roche Pharma Res & Early Dev, Basel, Switzerland
[3] Roche Innovat Ctr, New York, NY USA
[4] Roche Prod Ltd, Welwyn Garden City, England
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-077
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Bridging from Intravenous to Subcutaneous Formulation of Tocilizumab for Optimal Dose Regimens in Systemic Juvenile Idiopathic Arthritis (sJIA)
    Gibiansky, Leonid
    Gibiansky, Ekaterina
    Frey, Nicolas
    Mallalieu, Navita L.
    Petry, Claire
    Charoin, Jean-Eric
    Bao, Mm
    Mela, Christopher
    Douglass, Wendy
    Hsu, Joy C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S60 - S60
  • [2] Bridging from the Intravenous to Subcutaneous Formulation of Tocilizumab for Polyarticular Juvenile Idiopathic Arthritis and Systemic Juvenile Idiopathic Arthritis by Leveraging Prior Pharmacometrics Knowledge
    Hsu, Joy C.
    Gibiansky, Leonid
    Bharucha, Kamal
    Kadva, Alysha
    Kamal, Mohamed
    Mallalieu, Navita
    Frey, Nicolas
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S104 - S104
  • [3] Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
    Ruperto, Nicolino
    Brunner, Hermine, I
    Ramanan, Athimalaipet, V
    Horneff, Gerd
    Cuttica, Ruben
    Henrickson, Michael
    Anton, Jordi
    Lucica Boteanu, Alina
    Calvo Penades, Inmaculada
    Minden, Kirsten
    Schmeling, Heinrike
    Hufnagel, Markus
    Weiss, Jennifer E.
    Pardeo, Manuela
    Nanda, Kabita
    Roth, Johannes
    Rubio-Perez, Nadina
    Hsu, Joy C.
    Wimalasundera, Sunethra
    Wells, Chris
    Bharucha, Kamal
    Douglass, Wendy
    Bao, Min
    Mallalieu, Navita L.
    Martini, Alberto
    Lovell, Daniel
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2021, 60 (10) : 4568 - 4580
  • [4] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS
    Jafri, Shazad
    Ramanan, Athimalaipet V.
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Lovell, Daniel
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Hsu, Joy
    Bharucha, Kamal
    Wimalasundera, Sunethra
    Kadva, Alysha K.
    Upmanyu, Ruchi
    Mallalieu, Navita L.
    Martini, Alberto
    Brunner, Hermine
    RHEUMATOLOGY, 2017, 56 : 4 - 4
  • [5] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Ramanan, Athimalaipet V.
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Hsu, Joy
    Bharucha, Kamal
    Wimalasundera, Sunethra
    Kadva, Alysha K.
    Upmanyu, Ruchi
    Mallalieu, Navita L.
    Douglass, Wendy
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis
    Brunner, Hermine
    Ruperto, Nicola
    Martini, Alberto
    Ramanan, Athimalaipet
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Hsu, Joy
    Bharucha, Kamal
    Wimalasundera, Sunethra
    Kadva, Alysha K.
    Upmanyu, Ruchi
    Mallalieu, Navita L.
    Lovell, Daniel
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 59 - 60
  • [7] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA) TREATMENT IN TURKEY
    Erdogan-Ciftci, E.
    Yanik, L.
    Saka, O.
    VALUE IN HEALTH, 2019, 22 : S699 - S700
  • [8] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2019, 58
  • [9] Safety of Adalimumab±Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Brunner, Hermine I.
    Ruperto, Nicola
    Nanda, Kabita
    Toth, Mary
    Foeldvari, Ivan
    Bohnsack, John F.
    Milojevic, Diana
    Rabinovich, C. Egla
    Kingsbury, Daniel J.
    Marzan, Katherine
    Quartier, Pierre
    Minden, Kirsten
    Chalom, Elizabeth
    Horneff, Gerd
    Kuester, Rolf M.
    Dare, Jason A.
    Bereswill, Mareike
    Kalabic, Jasmina
    Kupper, Hartmut
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] CHANGES IN TREATMENT AND OUTCOMES OF PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA)
    Minden, K.
    Niewerth, M.
    Horneff, G.
    Thon, A.
    Ganser, G.
    Foeldvari, I.
    Klotsche, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 731 - 732
12345